Hepatocellular Cancer Therapy
New hepatocellular cancer therapy research from Pochon CHA University described
Published in Cancer Weekly, February 17th, 2009
Researchers detail in 'Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma,' new data in hepatocellular cancer. According to recent research from Korea, "Integrins are cell surface receptors for extracellular matrix (ECM) proteins that initiate signalling pathways that modulate proliferation, survival, invasion or metastasis. Consequently, integrins are potential targets for the treatment of cancer."
"In this study, we investigated whether single nucleotide polymorphisms (SNPs) in integrin alpha(V) (ITGAV) in a Korean population were associated with chronic hepatitis B...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-02-17)
More Articles from Cancer Weekly
- Adventrx Pharmaceuticals, Inc.
ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study - Array BioPharma Inc.
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009 - Bioengineering
Findings in bioengineering reported from A. Ambade and co-researchers - Cancer Gene Therapy
Findings in cancer gene therapy reported from M. Takanashi and co-researchers - Cancer Gene Therapy
New cancer gene therapy research from Fourth Military Medical University described - Cancer Gene Therapy
New cancer gene therapy research from W.F. Shi and colleagues discussed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
